Quote:
Originally Posted by whitev70r
We had this discussion before ... initially the efficacy rate was understood as (or implied to be) prevention rate ... which is the understanding of most vaccines. But what really happened in real life was that the vaccines reduced the severity of symptoms and (now looking back obvious) not a % to reflect prevention. But nevertheless, I much rather be out for 5-7 days with flu-like symptoms with the vaccine than risk having to go in the ICU or ventilator, etc.
|
That doesn't answer my question though. How are we supposed to make a quantitive judgement that the new Bivalent vaccine is better than another OG vaccine if they don't release the numbers? Even if it is Apples to Oranges numbers now, we have enough data to make a proper comparison now I'd hope.